Geometrically enhanced differential immunocapture (GEDI) and an antibody for prostate-specific membrane antigen (PSMA) are used for high-efficiency and high-purity capture of prostate circulating tumor cells from peripheral whole blood samples of castrate-resistant prostate cancer patients.

Background To update the Hong Kong Urological Association–Hong Society of Uro-Oncology consensus statements on management advanced prostate cancer, same panelists as in previous panel held a series meetings to discuss updated clinical evidence and experiences. Methods The were retained, deleted, or revised, new added. At final meeting, all reviewed amended appropriate, followed by voting. Resul...

despite the high rate of prostate cancer, the incidence of penile metastasis originating from prostate cancer is extremely rare, especially in the form of peyronie’s disease. moreover, brain metastasis, which is caused by prostate cancer, is not a common phenomenon and occurs mostly in older patients. herein, we report a case of a middle-aged man with penile and brain metastasis originating fro...